Our Patents

Our Patents

Follicum’s patent strategy is to secure a broad patent protection for the company’s product candidates. The company has received patent protection in major markets for the product candidate FOL-005, and variants thereof, both for the treatment of hair growth and inhibition of hair growth. Follicum is constantly reviewing all opportunities to improve the patent situation and the company will actively pursue an offensive patenting strategy to secure its future position. The company’s global patent strategy is focused on creating exclusivity and optimizing the value of the company’s product portfolio, especially in markets of high value for outlicensing.

patent-map-large-02
Patent Family Patent Application Approved Patents Validity
Patent 1: Stimulation of hair growth Australia, Brazil, Canada, China, Europe, Hong Kong, India, Japan, Russia, South Korea, USA Australia, Europe (Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Ireland, Italy, Netherlands, Norway, Poland, Switzerland, Spain, Sweden, Turkey), Hong Kong, Japan, Russia, USA 2032
Patent 2: Inhibition of hair growth Australia, Brazil, Canada, China, Europe, Israel, Japan, Mexico, Russia, Singapore, South Africa, South Korea, USA Pending 2035